In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

Practice Guideline Track on Diabetes, Pre-Diabetes and Cardiovascular Diseases

Guidelines into Practice

Diabetes and the Heart
Chronic Nursing Care
Risk Factors and Prevention

Contributor:  Special thanks to Lale Tokgozoglu from the EAPC - European Association of Preventive Cardiology,  (formerly European Association for Cardiovascular Prevention and Rehabilitation).

Based on the ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases.

Update - ESC Congress 2014 sessions

Session Presentation Slides Webcast

Diabetes management
Cardio-diabetology or diabeto-cardiology: conclusion and take home message.    

Cardiovascular prevention: interventions and outcomes
Comparison of treatment outcomes in patients with and without diabetes mellitus attending a multidisciplinary cardiovascular prevention programme (the EUROACTION trial)    

Diabetes management
Diabetic or not... Where is the sweet spot?
Dysglycaemia: what do the Guidelines say?  
Cardiovascular prevention: interventions and outcomes Efficacy of aspirin in people with diabetes: an individual participant data meta-analysis of 26 randomised trials    
Diabetes management Do we need cardiovascular disease risk models in diabetes? If so, when?  
Glucose-lowering and cardiovascular disease: placing recent trials into context.    
Optimal medical treatment: what do the Guidelines say?
Revascularisation in diabetes patients: CABG versus PCI.
Metformin, diabetes and heart failure: risks or benefits?    
My cardiovascular patient has dysglycaemia: what do I do? Case presentation.    
Optimal medical treatment, stenting or grafting? Who gets what? Case presentation.  
Optimal medical treatment: what do the Guidelines say?  
Renal expertise: what do the Guidelines say?    
Diabetes, dysglycaemia and metabolic syndrome What do the ESC Guidelines recommend as best management?    
Insulin resistance and risk of cardiovascular disease in postmenopausal women    


ESC Congress 2013 sessions

Session Presentation Slides Webcast
Diabetes, dysglycaemia and metabolic syndrome 

Epidemiology of diabetes and cardiovascular disease.       
Myocardial revascularisation in patients with diabetes - coronary artery bypass grafting or percutaneous coronary intervention?        
Management of cardiovascular disease in diabetes.    
Individualising diabetes care.    
Guidelines 2013 - what’s hot and what’s not.      
ESC Guidelines 2013 overview Diabetes, pre-diabetes in cardiovascular disease.          
New developments on prevention of diabetes: East versus West Preventive strategies and actions for the epidemic of diabetes in European countries.       
Optimal glucose control in acute coronary syndromes with a special reference to the Chinese patient.       
Improved medical therapy, PCI or CABG - the appropriate choice in patients with diabetes and coronary artery disease?        
Cardiodiabetology: do we need a new specialty? Diabetes and the heart.      
Diabetes management: lowering cardiovascular risk?         
Diabetic challenge for the interventional cardiologist.       
Diabetic cardiomyopathy: heart disease or diabetic disease?       
Meet the Guidelines Task Force II Diabetes in cardiovascular disease: questions and answers to the panellists.          
Cardiovascular disease and diabetes interactions    
Symposium New ways to screen for diabetes and pre-diabetes?     
Cardiovascular disease risk across the dysglycaemia spectrum: new paradigms at play.        
Update on managing dysglycaemia in acute coronary syndromes.       
Diabetes and heart failure: what are the management options.       
Clinical Trial Update Hot Line I: Updates on hypertension, heart failure and diabetes ORIGIN: Association between Hypoglycemia and Risk of Cardiovascular Events with Titrated Insulin Glargine or Standard Care            
Is there a role for non-statin based treatments in dyslipidaemia? Fibrates.      
Omega 3.     
Glucose levels and the heart - new concepts Prognostic significance of coronary flow reserve during acute hyperglycemia      
Impaired arterial wall properties in patients with diabetic retinopathy: the role of inflammation          
Performance of DPP-4-inhhibitors versus sulfonylureas on top of metformin in a real world setting - results of 2 years FU of DiaRegis